(Q37379395)

20 August 2017

1 reference

title

Does treatment with bisphosphonates endanger the human pregnancy? (English)

1 reference

20 August 2017

author

Chagit Klieger-Grossmann

series ordinal

2

object named as

Chagit Klieger-Grossmann

0 references

Gideon Koren

series ordinal

3

object named as

Gideon Koren

1 reference

20 August 2017

Nada Djokanovic

1

1 reference

20 August 2017

Chagit Klieger-Grossmann

series ordinal

2

1 reference

20 August 2017

publication date

1 December 2008

1 reference

Journal of Obstetrics and Gynaecology Canada

20 August 2017

published in

1 reference

20 August 2017

volume

30

1 reference

20 August 2017

issue

12

1 reference

20 August 2017

page(s)

1146-1148

1 reference

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

Bisphosphonates: preclinical aspects and use in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

Bisphosphonates: mode of action and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

Effects of the bisphosphonate, alendronate, on parturition in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

No effects of bisphosphonates on the human fetus

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

Antenatal administration of aminopropylidene diphosphonate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

Do bisphosphonates make children's bones better or brittle?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

The role of bisphosphonates in diseases of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934026-9

7 January 2021

10.1016/S1701-2163(16)34026-9

Identifiers

DOI

0 references

1 reference